Safety, Feasibility of Intravenous and Intrathecal Injection of Autologous Bone Marrow Derived Mesenchymal Stromal Cells in Patients with Amyotrophic Lateral Sclerosis: An Open Label Phase I Clinical Trial.

Leila Arab, Neda Jarooghi, Tina Bolurieh, Fatemeh Abbasi, Soura Mardpour, Azimyian, Fatemeh Moeininia, Saman Maroufizadeh, Leila Sanjari, SE Hosseini,

PubMed · 2019 · 32 citations · 35 references

DOIFull text

Open access

Abstract

This study has shown that IV and IT transplantation of BM-derived stromal cells is safe and feasible (Registration numbers: NCT01759797 and NCT01771640).

References

35